Jie Ni Selected Research

Nucleotides

1/2022	miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions.
1/2020	MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway.
3/2017	Promising therapeutic role of miR-27b in tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Ni Research Topics

Disease

36	Neoplasms (Cancer) 12/2023 - 12/2012
16	Neoplasm Metastasis (Metastasis) 11/2023 - 12/2012
15	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 12/2012
13	Inflammation (Inflammations) 06/2024 - 01/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 01/2017
6	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2016
5	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2013
5	Atherosclerosis 06/2014 - 04/2013
4	Carcinogenesis 12/2023 - 05/2010
4	Infections 09/2023 - 01/2021
4	Lung Neoplasms (Lung Cancer) 07/2023 - 10/2014
4	Cognitive Dysfunction 01/2022 - 01/2022
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2012
4	Diabetic Nephropathies (Diabetic Nephropathy) 03/2012 - 01/2011
4	Peritonitis 01/2010 - 12/2003
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2024 - 01/2020
3	Lymphatic Metastasis 11/2023 - 12/2013
3	COVID-19 09/2022 - 01/2021
3	Chronic Renal Insufficiency 01/2022 - 03/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2013
3	Pathologic Processes 01/2022 - 01/2017
3	Hypoxia (Hypoxemia) 01/2021 - 11/2016
3	Fibrosis (Cirrhosis) 01/2018 - 01/2013
3	Adenocarcinoma of Lung 01/2018 - 03/2017
3	Squamous Cell Carcinoma of Head and Neck 05/2015 - 05/2010
2	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 04/2024 - 11/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023 - 03/2023
2	Sepsis (Septicemia) 10/2023 - 01/2016
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2023 - 01/2021
2	Non-alcoholic Fatty Liver Disease 12/2022 - 09/2014
2	Circulating Neoplastic Cells 10/2022 - 01/2019
2	Chemotherapy-Related Cognitive Impairment 01/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2021
2	Vascular Calcification 01/2022 - 01/2012
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 01/2020
2	Proteinuria 01/2021 - 03/2012
2	Triple Negative Breast Neoplasms 01/2021 - 01/2021
2	Heart Failure 12/2020 - 11/2020
2	Pain (Aches) 12/2020 - 12/2013
2	Disease Progression 01/2019 - 01/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2016
2	Necrosis 05/2015 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 04/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2013 - 04/2013
2	Dyslipidemias (Dyslipidemia) 07/2013 - 04/2013

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2003
12	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2016
9	LipidsIBA 01/2023 - 01/2013
8	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
6	ApolipoproteinsIBA 05/2024 - 01/2013
5	CollagenIBA 01/2021 - 01/2012
5	LDL Receptors (LDL Receptor)IBA 01/2021 - 01/2012
5	Gefitinib (Iressa)FDA Link 01/2018 - 01/2017
4	Long Noncoding RNAIBA 11/2023 - 10/2018
4	LipopolysaccharidesIBA 10/2023 - 02/2005
4	VaccinesIBA 11/2021 - 04/2013
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2010 - 12/2003
3	RNA (Ribonucleic Acid)IBA 12/2023 - 06/2018
3	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2016
3	NucleotidesIBA 01/2022 - 03/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 01/2020
3	Epithelial Cell Adhesion MoleculeIBA 11/2018 - 12/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2003
3	AntigensIBA 10/2014 - 12/2012
3	hydroxide ionIBA 09/2014 - 01/2014
3	Triglycerides (Triacylglycerol)IBA 12/2013 - 01/2013
3	Apolipoproteins E (ApoE)IBA 12/2013 - 01/2013
3	CholesterolIBA 07/2013 - 01/2013
3	Angiotensin Receptor AntagonistsIBA 01/2013 - 03/2011
3	Irbesartan FDA LinkGeneric 03/2012 - 03/2011
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2010 - 12/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2024 - 01/2022
2	SolutionsIBA 01/2024 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 11/2019
2	Tyrosine Kinase InhibitorsIBA 03/2023 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 03/2023 - 01/2017
2	Nucleic AcidsIBA 01/2023 - 09/2022
2	trans-sodium crocetinate (crocetin)IBA 12/2020 - 11/2020
2	efatutazoneIBA 01/2018 - 12/2017
2	PPAR gammaIBA 01/2018 - 12/2017
2	T0901317IBA 01/2018 - 01/2017
2	Capsules (Microcapsules)IBA 01/2018 - 05/2010
2	Therapeutic UsesIBA 01/2018 - 12/2017
2	Liver X ReceptorsIBA 02/2017 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 02/2016 - 06/2013
2	CytokinesIBA 01/2016 - 03/2012
2	Vitamin D FDA LinkGeneric 09/2014 - 03/2014
2	C-Reactive ProteinIBA 12/2013 - 01/2012
2	Caseins (Casein)FDA Link 12/2013 - 07/2013
2	SREBP cleavage-activating proteinIBA 12/2013 - 01/2012

Therapy/Procedure

20	Therapeutics 10/2023 - 01/2013
13	Radiotherapy 03/2023 - 12/2012
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
5	Peritoneal Dialysis 01/2018 - 12/2003
3	Immunotherapy 01/2021 - 04/2013
2	Catheters 09/2023 - 12/2003
2	Precision Medicine 01/2022 - 01/2019
2	Castration 01/2014 - 12/2012